RepaglinideA Review of its Therapeutic Use in Type 2 Diabetes Mellitus

被引:0
作者
Christine R. Culy
Blair Jarvis
机构
[1] Adis International limited,
来源
Drugs | 2001年 / 61卷
关键词
Metformin; Glycaemic Control; Glibenclamide; Troglitazone; Repaglinide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1625 / 1660
页数:35
相关论文
共 248 条
[31]  
Tillil H(1994)Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells Diabetes Res 27 81-5
[32]  
Mooradian AD(1996)PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells Pharmacol Res 34 83-34
[33]  
Thurman JE(1995)Repaglinide and nateglinide are differentially affected by a single point mutation in SUR1/K Diabetologia 38 A195-7
[34]  
Berger W(1995)6.2 channels Eur J Endocrinol 132 14-81
[35]  
Brodows RG(1997)Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency Eur J Pharmacol 335 227-56
[36]  
Balfour JA(1994)Repaglinide preserves nutrient-stimulated biosynthetic activity in rat pancreatic islets Diabetologia 37 703-23
[37]  
Faulds D(2000)Repaglinide: unique mechanism of action in normal and metabolic stressed β cells [abstract] Diabetes Care 23 675-94
[38]  
Mark M(1999)Effect of repaglinide on insulin release in isolated islets of Langerhans is unaffected by metabolic stress induced by dinitrophenol [abstract] Diabetes Technol Ther 1 247-9
[39]  
Grell W(2000)Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats Diabetes Care 23 518-10
[40]  
Gromada J(1998)Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects Diabetologia 41 A235-41